Metastasis
Metastasis is the spread of cancer from the primary neoplasm (tumor) to distant organs. As primary tumors can often be removed by surgery and radiation it is metastases that contribute to the majority of morbidity and mortality associated with cancer.
Metastasis Products Targets
Products for Metastasis - Page 7
- Cat.No. Product Name Information/Activity
-
BCC5938
KF 38789
257292-29-8
-
BCC6229
LDV FITC
1207610-07-8
-
BCC6332
Leukadherin 1
Leukadherin-1 is a specific agonist of complement receptor 3 (CR3) and the leukocyte surface αMβ2 integrin CD11b/CD18.
-
BCC3943
MNS
MNS is a potent and selective inhibitor of Src and Syk tyrosine kinases.
-
BCC7458
OGT 2115
OGT 2115 is a potent, cell-permeable and orally active heparanase inhibitor with an IC50 of 0.4 μM. OGT 2115 has anti-angiogenic properties (IC50 of 1 μM). OGT 2115 also inhibits heparan sulfate degradation activity.
-
BCC6275
P11
848644-86-0
-
BCC6105
PM 102
1234564-95-4
-
BCC7694
RGDS peptide
Arg-Gly-Asp-Ser is an integrin binding sequence that inhibits integrin receptor function, decreases systemic inflammation via inhibition of collagen-triggered activation of leukocytes and attenuates expression of inflammatory cytokines, iNOS and MMP-9.
-
BCC7894
RWJ 50271
RWJ 50271 is an selective inhibitor of lymphocyte function-associated antigen-1/intercellular adhesion molecule-1(LFA-1/ICAM-1) interaction with an IC50 of 5.0 μM (HL60 cells).
-
BCC6216
TC-I 15
916734-43-5
